Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 250

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

1,184.50p
   
  • Change Today:
    -17.50p
  • 52 Week High: 1,989.00
  • 52 Week Low: 855.60
  • Currency: UK Pounds
  • Shares Issued: 240.87m
  • Volume: 297,863
  • Market Cap: £2,853.07m
  • RiskGrade: 246

Latest Deals

Traded Action Notifier PriceAmountValue
10-Apr-18 Transfer From Khalid Nabilsi 0.000p 14,165 £0.00

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
10-Apr-18 Transfer From Khalid Nabilsi 0.000p 14,165 £0.00

Director Shareholdings

Notifier Holding Value*
Said Darwazah 15,024,708 £177,967,666
Ali Al-Husry 7,118,180 £84,314,842
Mazen Darwazah 3,450,559 £40,871,871
Khalid Nabilsi 244,265 £2,893,319
Ronald L Goode 12,000 £142,140
Robert Pickering 10,000 £118,450
Pat Butler 3,875 £45,899
Pamela Kirby 3,317 £39,290
John J. Castellani 2,500 £29,612

Major Shareholders

Notifier** Holding Value*
Darhold Limited 60,000,000 £710,700,000
Boehringer Ingelheim Corporation; 40,000,000 £473,800,000
The Capital Group Companies, Inc 25,950,451 £307,383,092
Capital Group International 24,161,331 £286,190,966
DuPont Capital Management Corporation 19,232,981 £227,814,660
Strategic Equity Capital Plc 9,791,950 £115,985,648
Fidelity International 9,791,950 £115,985,648
Vanguard Healthcare Fund 7,284,981 £86,290,600

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,184.50p
Change Today -17.50p
% Change -1.46 %
52 Week High 1,989.00
52 Week Low 855.60
Volume 297,863
Shares Issued 240.87m
Market Cap £2,853.07m
RiskGrade 246

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.1% below the market average12.1% below the market average12.1% below the market average12.1% below the market average12.1% below the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
61.99% below the market average61.99% below the market average61.99% below the market average61.99% below the market average61.99% below the market average
43.75% below the sector average43.75% below the sector average43.75% below the sector average43.75% below the sector average43.75% below the sector average
Income
42.38% below the market average42.38% below the market average42.38% below the market average42.38% below the market average42.38% below the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Growth
75.64% below the market average75.64% below the market average75.64% below the market average75.64% below the market average75.64% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 7
Sell 1
Strong Sell 2
Total 14
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 05-Apr-18 24-Aug-17
Paid 24-May-18 22-Sep-17
Amount 23.00¢ 11.00¢

Trades for 19-Apr-2018

Time Volume / Share Price
16:53 804 @ 1,190.72p
16:53 200 @ 1,192.75p
16:53 204 @ 1,195.50p
16:53 318 @ 1,191.35p
16:52 200 @ 1,200.25p

HIK Key Personnel

CFO Khalid Nabilsi
CEO Sigurdur Olafsson

Top of Page